Press Releases

Training Peaks Becomes Official Software of Cycling Center

Training Peaks, LLC, provider of online training and analysis software for endurance athletes and coaches, has been selected as the exclusive software provider for Cycling Center. Training Peaks will be providing the Cycling Center coaching and medical staff the ability to monitor and plan workouts through a web-based platform called Training Peaks Coach Edition.

Ordinary People Can Create Extraordinary Products, Too

If you want to create an innovative new product, think like a consumer. Many successful products today, from the iPod to the OXO potato peeler, are designed with customer emotion, self-image and fantasy in mind. It's not all about product function, anymore. That's the focus of "The Design of Things to Come: How Ordinary People Can Create Extraordinary Products," a new book co-authored Peter Boatwright, Jonathan Cagan, and Craig Vogel. The book reveals a new generation of innovators and their products that feel perfect, fulfill deep unmet desires and transform consumer lifestyles. These products have benefits that are so self-evident, they often sell themselves.

AHRQ and Ad Council Encourage Patients To Ask Questions...

HHS' Agency for Healthcare Research and Quality joined with The Advertising Council today to launch a national public service advertising campaign designed to encourage adults to take a more proactive role in their health care. The campaign is being launched during national Patient Safety Awareness Week (March 4-10, 2007).

Video, 30 sec

Isis: Drug halved bad cholesterol

Isis Pharmaceuticals' experimental drug to lower cholesterol caused by an inherited condition showed positive results in a three-person Phase 2 study. The drug, which the Carlsbad-based company has not yet named, reduced the “bad,” or LDL, cholesterol levels by half, when given with other lipid lowering therapies, according to data presented at the American College of Cardiology meeting.

Geron Produces Human Embryonic Stem Cell-Derived Hepatocytes

Geron reports that it has developed standardized hepatocytes from human embryonic stem cells (hESCs) that can model human hepatic drug metabolism.

Intel To Build 300mm Wafer Fabrication Facility In China

Intel Corporation today announced plans to build a 300-millimeter (mm) wafer fabrication facility (fab) in the coastal Northeast China city of Dalian in Liaoning Province. The $2.5 billion investment for the factory designated Fab 68 will become Intel's first wafer fab in Asia and adds significant investment to Intel's existing operations in China.

World Future Society Forecasts For The Next 25 Years

Generation Y will migrate heavily overseas. Dwindling supplies of water in China will impact the global economy. Workers will increasingly choose more time over more money. We'll incorporate wireless technology into our thought processing by 2030. Children's "nature deficit disorder" will grow as a health threat.

Geron Presents New Data That Document Progress In Development Of Theraputic Products From Human Embryonic Stem Cells

Geron announced the presentation of new data that document the company’s progress in the development of first-in-class therapeutic products from human embryonic stem cells (hESCs) for the treatment of degenerative diseases. The data pertained to four products in development: (1) GRNOPC1, Oligodendroglial Progenitor Cells for acute spinal cord injury, (2) GRNIC1, Islet Clusters for diabetes, (3) GRNCM1, Cardiomyocytes for myocardial infarction and (4) osteoprogenitor cells for bone fractures and osteoporosis. Other presentations at the meeting described advances in hESC culture and derivation techniques and further characterization of hESC-derived hepatocytes for liver failure and drug metabolism testing.

PACS stem cell purifier

ValiRx have developed a new, in-line, cell purification device that allows stem cells to be selectively and efficiently removed from a blood sample in a more patient-friendly manner. The Polymer-Antibody Cell Separation (PACS) system works in an analogous manner to the affinity columns used to purify monoclonal antibodies. The separation and purification of stem cells from the blood is a necessity for both efficient stem cell research and the development of reproducible stem cell therapies.

Studies Show Geron's Stem Cell Therapeutic For Spinal Cord Injury Produces Nerve Growth Factors

Geron reported that GRNOPC1, the company’s human embryonic stem cell (hESC)-based oligodendroglial progenitor therapeutic, produces multiple nerve growth factors, proteins that stimulate the survival and regeneration of neurons damaged during spinal cord injury. The studies describe a newly discovered neurotrophic effect that, in addition to the previously documented in vivo remyelinating activity of these cells, serves as a second mechanism of action that demonstrates the product’s beneficial effects when injected into animal models of acute spinal cord injury.

New compound effectively treats fungal infections

Researchers unravel how a powerful new compound kills fungi by blocking protein synthesis. The human body is home to many different kinds of fungi. While the majority normally do not harm us, some fungi can cause unpleasant infections of skin, nails or lungs. "We have discovered a new compound that has the potential to treat common chronic nail infections caused by fungi. The compound, called AN2690, kills fungi by blocking their ability to make proteins. It has been very successful in clinical trials."